Clinical Parkinsonism & Related Disorders

Scope & Guideline

Bridging gaps in understanding Parkinsonism.

Introduction

Immerse yourself in the scholarly insights of Clinical Parkinsonism & Related Disorders with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCLIN PARKINSON RELAT / Clin. Parkinsonism Relat. Disord.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Clinical Parkinsonism & Related Disorders' focuses on advancing knowledge and understanding of Parkinsonism and related movement disorders through rigorous research and clinical studies. It aims to provide a platform for the dissemination of novel findings, treatment approaches, and management strategies in this field.
  1. Clinical Management and Treatment Strategies:
    The journal emphasizes research on clinical management approaches for Parkinson's disease and related disorders, including pharmacological treatments, surgical interventions, and rehabilitative therapies.
  2. Pathophysiology and Mechanisms of Disease:
    It explores the underlying biological and neurological mechanisms contributing to Parkinsonism and related disorders, focusing on genetic, environmental, and neurobiological factors.
  3. Non-Motor Symptoms and Quality of Life:
    Research on the non-motor symptoms of Parkinson's disease, such as cognitive impairment, depression, and anxiety, is a core area, with an emphasis on how these affect patients' quality of life.
  4. Innovative Research Methodologies:
    The journal promotes innovative research methodologies, including the use of technology in clinical assessments, machine learning applications, and novel therapeutic interventions.
  5. Patient-Centered Research:
    There is a consistent focus on understanding patient perspectives and experiences, particularly in the context of treatment adherence, caregiver burden, and health-related quality of life.
The journal has identified several emerging themes that reflect the current trends in Parkinsonism research. These themes highlight the evolving landscape of clinical practice and the growing recognition of various aspects of patient care.
  1. Holistic and Multidisciplinary Approaches:
    There is a growing trend towards integrating holistic care models that encompass physical, psychological, and social aspects of patient care, indicating a shift towards comprehensive management strategies.
  2. Technological Innovations in Treatment:
    Emerging studies focus on the use of technology, such as telehealth, wearables, and mobile applications, to enhance treatment adherence and monitor symptoms in real-time.
  3. Focus on Non-Motor Symptoms:
    An increasing number of publications are addressing non-motor symptoms, such as sleep disturbances, cognitive decline, and psychiatric disorders, recognizing their significant impact on overall patient health.
  4. Patient-Centric Research:
    There is an emphasis on incorporating patient-reported outcomes and experiences into clinical research, reflecting a broader trend towards patient-centered care in movement disorders.
  5. Genetic and Biomarker Research:
    The exploration of genetic predispositions and potential biomarkers for Parkinson's disease is gaining traction, as researchers seek to better understand the disease's etiology and progression.

Declining or Waning

While the journal continues to publish a wide range of topics, certain areas have shown a decline in research focus over recent years. This may reflect shifts in clinical priorities or emerging insights that overshadow previous themes.
  1. Traditional Pharmacological Treatments:
    Research on older, traditional pharmacological treatments has decreased as newer therapies and delivery methods gain prominence, indicating a shift towards exploring more innovative treatment options.
  2. Epidemiological Studies:
    There has been a noticeable reduction in the publication of epidemiological studies focused on the prevalence and incidence of Parkinson's disease, possibly due to an increased focus on clinical and experimental research.
  3. Historical Case Studies:
    The journal has seen a decline in the publication of historical case studies related to Parkinson's disease, as the emphasis has shifted towards contemporary clinical trials and evidence-based practices.
  4. Generalized Movement Disorders:
    There is less focus on generalized movement disorders that do not specifically relate to Parkinson's disease, as the journal increasingly prioritizes research directly connected to Parkinsonism.
  5. Basic Science Research:
    Basic science research, while still important, appears to be waning in favor of more applied clinical research that directly addresses patient care and treatment outcomes.

Similar Journals

Neurology and Clinical Neuroscience

Advancing the frontiers of neurology and clinical practice.
Publisher: WILEYISSN: 2049-4173Frequency: 6 issues/year

Neurology and Clinical Neuroscience, published by WILEY, is a pivotal peer-reviewed journal dedicated to advancing knowledge in the fields of neurology and clinical neuroscience. With an ISSN of 2049-4173, it encompasses a diverse range of topics related to neurological disorders, offering a platform for groundbreaking research and clinical practices. Although the journal does not currently operate under an open access model, it aims to foster an inclusive academic environment by providing high-quality content that is accessible to both specialists and general practitioners in the medical community. Despite its relatively recent establishment from 2013 to 2024, the journal has gained recognition with Scopus rankings highlighting its role in clinical neurology and neuroscience spheres. It serves as an essential resource for researchers, professionals, and students seeking to expand their understanding and engage in current discussions surrounding neurological health and diseases.

EUROPEAN NEUROLOGY

Elevating Understanding of Neurological Disorders
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

Parkinsons Disease

Exploring breakthroughs in Parkinson's research and treatment.
Publisher: HINDAWI LTDISSN: 2090-8083Frequency:

Parkinson's Disease is a prestigious open access journal dedicated to advancing the field of neurology with a special emphasis on Parkinson's disease and related movement disorders. Published by Hindawi Ltd, the journal has established itself as a vital resource since its inception in 2008, transitioning to an open access model in 2010. Featuring the ISSN 2090-8083 and E-ISSN 2042-0080, it has rapidly gained traction in the academic community, currently ranked Q2 in clinical neurology and psychiatry in the 2023 category quartiles, highlighting its significance and quality within the field. With Scopus rankings placing it in the top percentiles for neuroscience and psychiatry, it provides researchers, healthcare professionals, and students with cutting-edge research, reviews, and clinical studies. Situated in London, England, this journal encourages submissions that contribute to the understanding and management of Parkinson's disease, showcasing the latest findings and fostering collaboration among researchers worldwide.

Clinical and Experimental Gastroenterology

Elevating the standard of care through groundbreaking research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Epilepsy & Behavior Reports

Exploring Innovations in Epilepsy Research and Treatment
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

Annals of Indian Academy of Neurology

Elevating Standards in Neurological Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Research and Reviews in Parkinsonism

Exploring new horizons in Parkinson's disease management.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Research and Reviews in Parkinsonism is an esteemed open access journal dedicated to advancing knowledge and understanding in the field of Parkinson's disease and related disorders. Published by DOVE MEDICAL PRESS LTD, this journal aims to disseminate high-quality research articles, reviews, and clinical studies that focus on innovative approaches to the management, treatment, and understanding of Parkinsonism. Since its inception as an open access journal in 2019, it has become a vital resource for researchers, clinicians, and students alike, facilitating the rapid exchange of information and fostering collaboration across multidisciplinary fields. With its commitment to enhancing the visibility and accessibility of research findings, Research and Reviews in Parkinsonism plays a crucial role in shaping the future of Parkinson's disease research globally. Readers can access the journal online, ensuring that vital information is readily available to all stakeholders in the healthcare community.

Current Journal of Neurology

Empowering knowledge in the realm of neurological disorders.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

REVISTA DE NEUROLOGIA

Illuminating Pathways in Neurological Health
Publisher: REVISTA DE NEUROLOGIAISSN: 0210-0010Frequency: 12 issues/year

REVISTA DE NEUROLOGIA is a distinguished academic journal focusing on the broad fields of neurology and medicine, published in Spain since its inception in 1959. The journal plays a vital role in disseminating significant research findings, clinical studies, and advancements in neurological science, catering to an audience of researchers, clinicians, and students alike. With an ISSN of 0210-0010 and an E-ISSN of 1576-6578, this quarterly publication has maintained its commitment to enhancing the understanding of neurological disorders and therapies through rigorous peer-reviewed articles. While currently not classified as open access, it is indexed in Scopus, holding a rank of #253 out of 400 in the category of Medicine (Neurology), reflecting its relevance in the field with a 36th percentile. The journal is positioned within the Q3 quartile for both Medicine (miscellaneous) and Clinical Neurology categories as of 2023. Based in Barcelona, Spain, it is a vital resource for anyone devoted to the advancement of knowledge and practice in neurology.

Neurodegenerative Disease Management

Advancing Knowledge in Neurodegenerative Disease Management
Publisher: FUTURE MEDICINE LTDISSN: 1758-2024Frequency: 6 issues/year

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.